EAU 2008 - Combined Targeting of Androgen Receptor and Protein Kinase A Signaling Pathways Increase Inhibition of Prostate Tumor Growth
MILAN, ITALY (UroToday.com) - In the androgen ablation-resistant stage of prostate cancer, androgen receptor (AR) activation may occur through ligand-independent interaction of AR with other signaling pathways, including protein kinase A (PKA).
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |